Preoperative infliximab is not associated with an increased risk of short-term postoperative complications after restorative proctocolectomy and ileal pouch-anal anastomosis.
BACKGROUND
Considerable controversy exists over whether the preoperative use of infliximab (IFX) for refractory ulcerative colitis (UC) increases the risk for surgical complications after restorative proctocolectomy and ileal pouch-anal anastomosis (IPAA). The aim of this study was to assess the association between preoperative IFX use and short-term surgical complications in a single-surgeon cohort at a tertiary care academic center.


METHODS
UC patients who underwent IPAA from September 2005 through May 2009 were retrospectively identified. Twenty-nine patients treated with IFX within 12 weeks of surgery and 52 non-IFX control subjects were identified. Short-term postoperative outcomes were compared between groups occurring within 30 days of loop ileostomy closure.


RESULTS
Patients were similar with respect to demographics, co-morbidities, rate of emergency surgery, hand-sewn anastomosis, and preoperative use of cyclosporine, azathioprine, and high-dose steroids. IFX patients were more likely to have received a laparoscopic hand-assisted IPAA, low-, medium-, and any-dose steroids, 6-mercaptopurine (6-MP), methotrexate, and to have failed medical therapy. There was no short-term mortality. Overall postoperative and infectious complications were similar between IFX and non-IFX groups. Multivariate regression models revealed no independent predictors for postoperative complications when including IFX [odds ratio (OR) 0.78, p = 0.67], laparoscopic hand-assisted IPAA, 6-MP, methotrexate, steroids, failure of medical therapy, and body mass index.


CONCLUSIONS
Preoperative IFX use was not associated with an increased risk of short-term postoperative complications after IPAA.
Department of Surgery, Boston University School of Medicine, 88 East Newton Street, C500, Boston, MA 02118, USA.
Melanie L
ML
Gainsbury
Daniel I
DI
Chu
Lauren A
LA
Howard
Jennifer A
JA
Coukos
Francis A
FA
Farraye
Arthur F
AF
Stucchi
James M
JM
Becker
D000328:Adult; D001003:Anal Canal / Q000601:surgery; D000714:Anastomosis, Surgical / Q000009:adverse effects; D057868:Anastomotic Leak / Q000209:etiology*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D003093:Colitis, Ulcerative / Q000188:drug therapy* / Q000601:surgery*; D039021:Colonic Pouches / Q000009:adverse effects; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D007082:Ileum / Q000601:surgery; D000069285:Infliximab; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D011292:Premedication; D057234:Preoperative Period; D016737:Proctocolectomy, Restorative / Q000009:adverse effects*; D012189:Retrospective Studies; D012307:Risk Factors; D013530:Surgical Wound Infection / Q000209:etiology*; D055815:Young Adult
D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab
J Am Coll Surg. 2007 May;204(5):956-62; discussion 962-3
17481518
Annu Rev Med. 1994;45:491-503
8198398
Clin Gastroenterol Hepatol. 2006 May;4(5):621-30
16678077
Inflamm Bowel Dis. 2009 Jan;15(1):146-9
19009603
J Gastrointest Surg. 2008 Oct;12(10):1730-6; discussion 1736-7
18709514
Expert Opin Pharmacother. 2008 Feb;9(3):447-57
18220494
Inflamm Bowel Dis. 2009 Jul;15(7):1062-70
19161179
Aliment Pharmacol Ther. 2010 Feb 15;31(4):486-92
19925496
Arthritis Rheum. 2006 Apr 15;55(2):333-7
16583385
Foot Ankle Int. 2004 May;25(5):331-5
15134615
Surg Endosc. 2010 Feb;24(2):270-6
19533235
J Rheumatol. 2007 Apr;34(4):689-95
17117492
J Infect Dis. 1987 Dec;156(6):967-73
3680996
Obstet Gynecol. 2000 Mar;95(3):367-71
10711546
Am J Gastroenterol. 2004 May;99(5):878-83
15128354
Lancet. 2003 Jun 14;361(9374):2032-5
12814714
Ann Surg. 2010 Mar;251(3):436-40
20134312
Aliment Pharmacol Ther. 2004 Apr 1;19(7):749-54
15043515
Surg Endosc. 2002 May;16(5):855-8
11997837
Dis Colon Rectum. 2008 Aug;51(8):1202-7; discussion 1207-10
18536964
Ann Surg. 2008 Apr;247(4):627-32
18362625
Gastroenterology. 1992 Nov;103(5):1444-51
1358741
Surg Endosc. 2010 Aug;24(8):1866-71
20108148